chr19-17837148-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_000215.4(JAK3):c.1767C>T(p.Gly589Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,405,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000215.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JAK3 | NM_000215.4 | c.1767C>T | p.Gly589Gly | synonymous_variant | Exon 13 of 24 | ENST00000458235.7 | NP_000206.2 | |
JAK3 | XM_047438786.1 | c.1767C>T | p.Gly589Gly | synonymous_variant | Exon 13 of 24 | XP_047294742.1 | ||
JAK3 | XM_011527991.3 | c.1767C>T | p.Gly589Gly | synonymous_variant | Exon 13 of 14 | XP_011526293.2 | ||
JAK3 | XR_007066796.1 | n.1817C>T | non_coding_transcript_exon_variant | Exon 13 of 20 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152074Hom.: 0 Cov.: 31 FAILED QC
GnomAD3 exomes AF: 0.00000583 AC: 1AN: 171516Hom.: 0 AF XY: 0.0000110 AC XY: 1AN XY: 91216
GnomAD4 exome AF: 0.0000199 AC: 28AN: 1405938Hom.: 0 Cov.: 32 AF XY: 0.0000144 AC XY: 10AN XY: 694338
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152074Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74270
ClinVar
Submissions by phenotype
T-B+ severe combined immunodeficiency due to JAK3 deficiency Pathogenic:1Uncertain:1
- -
This sequence change affects codon 589 of the JAK3 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the JAK3 protein. RNA analysis indicates that this variant induces altered splicing and likely results in the loss of 7 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is present in population databases (rs193922362, ExAC 0.01%). This variant has been observed in individual(s) with severe combined immunodeficiency (PMID: 9354668, 23384681, 32754152). This variant is also known as a C to T transition at nt 1862. ClinVar contains an entry for this variant (Variation ID: 36416). Studies have shown that this variant results in the activation of a cryptic splice site in exon 13 (PMID: 9354668). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Severe combined immunodeficiency disease Pathogenic:1
- -
not provided Pathogenic:1
The c.1767 C>T variant has been published previously in association with SCID (Candotti et al., 1997; Cattaneo et al., 2013). The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. While this variant leads to a synonymous amino acid change, several in-silico splice prediction models predict that c.1767 C>T creates a cryptic donor site which may supplant the natural donor site of intron 13 and lead to abnormal gene splicing. Additionally, functional studies have shown that the variant causes the loss of 21 nucleotides upstream of the natural splice donor site, leading to impaired function of the JAK3 protein (Candotti et al., 1997). Therefore, we consider this variant to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at